Clinical Ink Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Winston-Salem, NC USA
Total Funding:$21.7M
Industry:Pharma
Founded:2007
Lead Investor(s):RTI International

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Clinical Ink's estimated annual revenue is currently $29.9M per year.
  • Clinical Ink received $Undisclosed in venture funding in May 2018.
  • Clinical Ink's estimated revenue per employee is $201,000
  • Clinical Ink's total funding is $21.7M.

Employee Data

  • Clinical Ink has 149 Employees.
  • Clinical Ink grew their employee count by 9% last year.
  • Clinical Ink currently has 9 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
BioDelivery Sci...
$5.6M1857%N/A-N/A
Quality Chemica...
$39.4M1968%N/A-N/A
PPD
$2147.5M24959N/AN/A-N/A
LMK Clinical Re...
$8.6M435%N/A-N/A
PMG Research
$49.2M245-1%N/A-N/A
3D Communicatio...
$15.1M751%N/A-N/A
WEP Clinical
$12.3M6130%N/A-N/A
Tanner Pharma G...
$12.3M6113%N/A-N/A
Nuventra Pharma...
$20.1M10012%N/A-N/A
Flow Sciences
$10.5M52-2%N/A-N/A
Missing a competitor? Contribute!?
Submit

Clinical Ink is the leading provider of eSource solutions for the global clinical trials market. Founded in 2007, Clinical Ink® is transforming clinical development with innovative technologies that make clinical research easier for sites, sponsors and patients. Clinical Ink's SureSource® platform directly captures eSource data and documents and improves patient engagement while streamlining clinical development. Clinical Ink maintains offices in Winston-Salem, NC, and Philadelphia, PA. Find more at www.clinicalink.com. Our customer base includes pharmaceutical and medical device companies, academic institutions, and CROs. SureSource has been successfully used in a wide range of therapeutic areas including CNS, infectious diseases, dermatology, gastroenterology, and virology.

keywords:Healthcare,Pharmaceuticals

149

Number of Employees

$29.9M

Revenue (est)

9

Current Jobs

9%

Employee Growth %

$21.7M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Clinical Ink News

09/03/2019 - Clinical Ink's Jonathan R. Andrus Receives 2019 Inspire ...

Winston-Salem, N.C.; May 14, 2019 (PR Newswire) – Clinical Ink, a global clinical trial technology company that is transforming the clinical trial ...

09/08/2019 - Lupin, Boehringer Ingelheim ink $700m licensing deal for anti-cancer drug

Lupin's MEK inhibitor compound completed initial Phase-I clinical trial in the UK. Now, Boehringer will take over the clinical development of the ...

09/03/2019 - CDC issues warning after outbreak of vaping-related illnesses

CDC, FDA, state and local health departments, and other clinical and public health partners are investigating a multistate outbreak of severe ...

Clinical Ink Funding

DateAmountRoundLead InvestorsReference
2013-10-17$4.3MBFCA Venture PartnersArticle
2015-03-19$UndisclosedUndisclosedMPM CapitalArticle
2018-05-15$UndisclosedUndisclosedRTI InternationalArticle

Clinical Ink Executive Hires

DateNameTitleReference
2016-03-11Stephen BoccardoChief Commercial OfficerArticle

Clinical Ink Acquisitions

DateCompany NameAmountNotesReference
2015-03-19CentrosHealthArticle